Clinical impact of cardiac magnetic resonance in patients with suspected coronary artery disease associated with chronic kidney disease (AQUAMARINE-CKD study): study protocol for a randomized controlled trial

• Published in: Current controlled trials in cardiovascular medicine Vol. 23; no. 1; p. 904
• Main Authors: Noguchi, Teruo, Ota, Hideki, Matsumoto, Naoya, Morita, Yoshiaki, Oshita, Akira, Kawasaki, Eiji, Kawasaki, Tomohiro, Moriwaki, Kensuke, Kato, Shingo, Fukui, Kazuki, Hoshi, Tomoya, Watabe, Hiroaki, Kanaya, Tomoaki, Asaumi, Yasuhide, Kataoka, Yu, Otsuka, Fumiyuki, Takagi, Kensuke, Yoneda, Shuichi, Sawada, Kenichiro, Iwai, Takamasa, Matama, Hideo, Honda, Satoshi, Fujino, Masashi, Miura, Hiroyuki, Nishimura, Kunihiro, Takase, Kei
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 24.10.2022; BioMed Central; BMC
• Subjects: Angiography; Blood pressure; Calcification; Cardiac magnetic resonance; Cardiovascular disease; Care and treatment; Chronic kidney disease; Chronic kidney failure; Complications and side effects; Consent; Coronary artery disease; Coronary heart disease; Coronary vessels; Cost analysis; Diabetes; Disease prevention; Electrocardiography; High density lipoprotein; Hospitals; Hypertension; Ischemia; Kidney diseases; Laboratories; Magnetic resonance angiography; Medical imaging; Methods; Mortality; Participation; Patients; Plaque imaging; Prevention; Risk factors; Scintigraphy; Study Protocol; Thoracic surgery; Tomography; Vein & artery diseases; Japan
• ISSN: 1745-6215; 1745-6215
• DOI: 10.1186/s13063-022-06820-w

Abstract Background Although screening for coronary artery disease (CAD) using computed tomography coronary angiography in patients with stable chest pain has been reported to be beneficial, patients with chronic kidney disease (CKD) might have limited benefit due to complications of contrast agent nephropathy and decreased diagnostic accuracy as a result of coronary artery calcifications. Cardiac magnetic resonance (CMR) has emerged as a novel imaging modality for detecting coronary stenosis and high-risk coronary plaques without contrast media that is not affected by coronary artery calcification. However, the clinical use of this technology has not been robustly evaluated. Methods AQUAMARINE-CKD is an open parallel-group prospective multicenter randomized controlled trial of 524 patients with CKD at high risk for CAD estimated based on risk factor categories for a Japanese urban population (Suita score) recruited from 6 institutions. Participants will be randomized 1:1 to receive a CMR examination that includes non-contrast T1-weighted imaging and coronary magnetic angiography (CMR group) or standard examinations that include stress myocardial scintigraphy (control group). Randomization will be conducted using a web-based system. The primary outcome is a composite of cardiovascular events at 1 year after study examinations: all-cause death, death from CAD, nonfatal myocardial infarction, nonfatal ischemic stroke, and ischemia-driven unplanned coronary intervention (percutaneous coronary intervention or coronary bypass surgery). Discussion If the combination of T1-weighted imaging and coronary magnetic angiography contributes to the risk assessment of CAD in patients with CKD, this study will have major clinical implications for the management of patients with CKD at high risk for CAD. Trial registration Japan Registry of Clinical Trials (jRCT) 1,052,210,075. Registered on September 10, 2021.